Healthcare -
Biotechnology - NASDAQ - US
$ 21.24
0.341 %
$ 651 M
Market Cap
-4.03
P/E
ANAB - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ANAB - AnaptysBio, Inc.
127 M
LAST VALUE
69.90%
2 YEAR CAGR
97.80%
5 YEAR CAGR
38.44%
10 YEAR CAGR